特应性男孩 14 岁患中心性浆液性脉络膜视网膜病变：病例报告。
Central Serous Chorioretinopathy in a 14-year-old atopic boy: a case report.
机构信息
Ophthalmology Department, Circolo and Fondazione Macchi Hospital, ASST Sette Laghi, Varese, Italy.
University of Insubria, Department of Medicine and Surgery, Via Guicciardini 9, 21100, Varese, Italy.
出版信息
Ital J Pediatr. 2023 Jan 3;49(1):1. doi: 10.1186/s13052-022-01386-4.
BACKGROUND
Corticosteroids are widely used in medicine. Few cases of central serous chorioretinopathy (CSC) have been reported following topical corticosteroid administration. We describe the first case of pediatric CSC related to topical corticosteroid administration.
CASE PRESENTATION
A 14-year-old boy presented with decreased vision, pigment epithelial detachments, and serous retinal detachments in the right eye after starting treatment for atopic dermatitis with Betamethasone Valerate 0.1% topical ointment. His condition resolved 2 weeks after discontinuing the steroid and administering Bromfenac 0.9 mg/ml eyedrops.
CONCLUSIONS
Although the pathogenesis of CSC is poorly understood, ophthalmologists should be informed about the potential link between CSC and topical corticosteroid treatment, and they should be aware that CSC might, albeit infrequently, affect children.
背景
皮质类固醇在医学中被广泛应用。局部皮质类固醇给药后引发中心性浆液性脉络膜视网膜病变（CSC）的情况很少见。我们描述了首例与局部皮质类固醇给药相关的儿科 CSC 病例。
病例介绍
一名 14 岁男孩因特应性皮炎开始使用倍他米松戊酸酯 0.1%的局部软膏治疗后，右眼视力下降，出现色素上皮脱离和浆液性视网膜脱离。停用类固醇并给予溴芬酸钠 0.9mg/ml 滴眼剂 2 周后，他的病情得到缓解。
结论
尽管 CSC 的发病机制尚未完全了解，但眼科医生应该了解 CSC 与局部皮质类固醇治疗之间可能存在的联系，并且应该意识到 CSC 虽然不常见，但可能会影响儿童。
Zotero 插件